Fractin A marker of apoptosis Antibody
Rabbit polyclonal antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB |
---|---|
Reactivity | Human, Rat |
Host | Rabbit |
Clonality | polyclonal |
Calculated MW | 32 KDa |
Gene Name | fragment of Actin |
---|---|
Target/Specificity | Synthetic peptide corresponding to amino acid residues from the C terminal region of the 32-kDa actin fragment. |
Dilution | WB~~ 1:1000 |
Format | neat serum. |
Antibody Specificity | Specific for the ~ 32 kDa fractin protein in Western blots with no reactivity to intact actin. There is often a ladder of smaller bands in cells or culture or in vivo preparations due to further degradation by other proteases. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Precautions | Fractin A marker of apoptosis Antibody is for research use only and not for use in diagnostic or therapeutic procedures. |
Shipping | Blue Ice |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Fractin (fragment of actin) is a caspase-specific cleavage product of actin and serves as a novel marker of apoptosis-related events. The antibody has been shown to detect the processes and cell bodies of degenerating neurons and plaque-associated microglia in Alzheimer’s disease (Yang et al., 1998). It has recently been reported that Fractin may have a functional role in apoptotic signaling in oligodendrocytes (Schulz, R., et al., Glia, 2009, in press).
References
Yang, F, et al., Antibody to Caspase-Cleaved Actin Detects Apoptosis in Differentiated Neuroblastoma and Plaque-Associated Neurons and Microglia in Alzheimer's disease. American Journal of Pathology, 1998, Vol. 152, No. 2, p. 379-389.
Rossiter, JP, et al., Caspase-cleaved actin (fractin) immunolabeling of Hirano bodies. Neuropathol Appl Neurobiol. 2000 Aug; 26(4):342-6.
Asamec, E, et al., Multiple-label immunocytochemistry for the evaluation of nature of cell death in experimental models of neurodegeneration. Brain Res Protoc. 2001 Jul;7(3):193-202.
Chen, TA, et al., Inhibition of caspase-3-like activity reduces glutamate induced cell death in adult rat retina. Brain Res. 2001 Jun 15;904(1):177-88.
Rossiter, JP, et al., Caspase-3 activation and caspase-like proteolytic activity in human perinatal hypoxic-ischemic brain injury. Acta Neuropathol. 2002 Jan;103(1):66-73.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.